Daclatasvir
Daclatasvir is a premium clinical composition utilized extensively under specialized clinical prescriptions.
Formulations based on "Daclatasvir" (6)
Qurdac
Daclatasvir
Qurdac 60 mg (Daclatasvir) is a direct-acting antiviral (DAA) inhibitor drug specified for patients with chronic Hepatitis C viral (HCV) infection. Among 9 different genotypes of HCV, Qurdac 60 mg ...
Hepcdac
Daclatasvir
Hepcdac 60 mg (Daclatasvir) is an anti-viral agent indicated for patients with different variants of hepatitis C viral (HCV) infection. Hepatitis C is caused by a single-stranded (ss) RNA virus whi...
DaciHep 60 mg (Daclatasvir)
Daclatasvir
Hepatitis C viral (HCV) infection is a liver disease caused by single-stranded (ss) RNA viruses categorized into 9 distinct genotypes. DaciHep 60 mg (Daclatasvir) with its potent inhibitory action ...
Daclahep
Daclatasvir
Daclahep 60 mg (Daclatasvir) is an anti-viral agent indicated for patients with different variants of hepatitis C viral (HCV) infection. Hepatitis C is caused by a single-stranded (ss) RNA virus wh...
Dacikast
Daclatasvir
Dacikast 60 mg (Daclatasvir) is a direct-acting antiviral (DAA) inhibitor drug specified for patients with chronic Hepatitis C viral (HCV) infection. It is employed in patients suffering from HCV g...
Mydekla 60
Daclatasvir
MyDekla 60 mg (Daclatasvir Dihydrochloride) is a direct-acting antiviral (DAA) inhibitor drug specified for patients with chronic Hepatitis C viral (HCV) infection with genotype 1 or 3. After enter...